Details

Dejavniki uspešnega uvajanja celovite programske rešitve v podjetje : magistrsko delo
ID Plavšić, Maja (Author), ID Hočevar, Marko (Mentor) More about this mentor... This link opens in a new window

URLURL - Presentation file, Visit http://www.cek.ef.uni-lj.si/magister/plavsic4260-B.pdf This link opens in a new window

Language:Slovenian
Keywords:informatika, poslovna inteligenca, informacijska tehnologija, informacijski sistemi, podjetje, poslovanje podjetja, projekti, primeri
Work type:Master's thesis/paper
Typology:2.09 - Master's Thesis
Organization:EF - School of Economics and Business
Place of publishing:Ljubljana
Publisher:[M. Plavšić]
Year:2021
Number of pages:III, 65 str.
PID:20.500.12556/RUL-130698 This link opens in a new window
UDC:659.2
COBISS.SI-ID:71681795 This link opens in a new window
Publication date in RUL:18.09.2021
Views:1884
Downloads:49
Metadata:XML DC-XML DC-RDF
:
PLAVŠIĆ, Maja, 2021, Dejavniki uspešnega uvajanja celovite programske rešitve v podjetje : magistrsko delo [online]. Master’s thesis. Ljubljana : M. Plavšić. [Accessed 26 March 2025]. Retrieved from: http://www.cek.ef.uni-lj.si/magister/plavsic4260-B.pdf
Copy citation
Share:Bookmark and Share

Secondary language

Language:English
Title:Factors of successful implementation of enterprise resource planning
Keywords:informatics, business intelligence system, information technology, information systems, enterprises, company performance, projects, cases

Similar documents

Similar works from RUL:
  1. Review of the treatment of advanced non-small-cell lung cancer patients with mutation in the epidermal growth factor during the years of 2010 and 2014 at the University Clinic Golnik
  2. Vpliv izražanja receptorja za inzulinu podoben rastni dejavnik 1 (IGF1R) na preživetje pri razsejanem nedrobnoceličnem raku pljuč
  3. Evaluation of possible pembrolizumab dosing regimen racionalisation in advanced non-small cell lung cancer
Similar works from other Slovenian collections:
  1. Epidermal growth factor receptor mutations and treatment of non-small-cell lung cancer
  2. Sequential treatment with afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
  3. Multicenter evaluation of the fully automated PCR-based Idylla EGFR Mutation Assay on formalin-fixed, paraffin-embedded Q1 tissue of human lung cancer
  4. Trans-esophageal endobronchial ultrasound-guided needle aspiration (EUS-B-NA)
  5. Real-world testing practices, treatment patterns and clinical outcomes in patients from Central Eastern Europe with EGFR-mutated advanced non-small cell lung cancer

Back